pharmaphorum July 24, 2025
Jonah Comstock

Back in May, health data company Datavant announced its plans to acquire Aetion, creating a formidable player in the real-world data space. Now that the acquisition has closed, the pharmaphorum podcast welcomes Arnaub Chatterjee, president and general manager of life sciences at Datavant, to discuss what that integration will look like — and what the implications are for the pharma industry.

Chatterjee discusses how the acquisition came about and what the strategic fit looks like between the two organisations, as well as how they will complement each other going...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Big Data, Conferences / Podcast, Mergers & Acquisitions / JV, Technology, Trends
Professionalism 2026: Data Driven Doctor in ‘Most Innovative’ Arena
AI May No Longer Require Big Data Centers to Scale
5 Data Ethics Principles Every Business Needs To Implement In 2026
How Do I Know if My Health Data Is Bad?
Data Benefits AI; AI Benefits Data

Share Article